-
Study Links Mediterranean Diet to Lower Multiple Sclerosis Risk Levels
27 Dec 2025 14:46 GMT
… risk of developing multiple sclerosis (MS).
Published in the Multiple Sclerosis Journal, the findings … and risk of multiple sclerosis: A prospective cohort study. Multiple Sclerosis Journal. 2025;0 …
-
Targeted-Immunomodulatory Nanomedicines for the Treatment of Autoimmune Diseases via Multiple Administration Routes
27 Dec 2025 01:44 GMT
… in a model of autoimmune multiple sclerosis induced with the MOG35- … nodes for tolerance induction against multiple sclerosis.113 SC administered nanoparticles … the symptoms associated with multiple sclerosis in a murine multiple sclerosis model induced by …
-
Mixed Results for Lipoic Acid in Multiple Sclerosis
26 Dec 2025 10:54 GMT
… outcomes in patients with progressive multiple sclerosis (MS) compared to placebo in … ’t work clinically in progressive multiple sclerosis the way we hoped,” lead … Department of Veterans Affairs, National Multiple Sclerosis Society, MS Canada, and National …
-
Mediterranean diet may significantly lower Multiple Sclerosis risk, especially in younger adults and nonsmokers, Swedish study finds
26 Dec 2025 09:05 GMT
… lower the risk of developing multiple sclerosis (MS), with the greatest protective … on December 15 in the Multiple Sclerosis Journal.
According to the Medscape … of Milano-Bicocca, Milan, said.
Multiple sclerosis (MS) is a long-term …
-
Petition to bring Waterford man with multiple sclerosis back from nursing home in Wexford
25 Dec 2025 06:40 GMT
… old David is living with multiple sclerosis and currently resides in a … in Waterford for people with multiple sclerosis and in nursing homes, and … the amount of people with multiple sclerosis under the age of 65 …
-
<![CDATA[NeurologyLive® Year in Review 2025: Top Interviews in Multiple Sclerosis Care ]]>
24 Dec 2025 15:26 GMT
… Research Strategies to Address Multiple Sclerosis Progression Earlier: Ludwig Kappos … Advancements and Challenges in Pediatric Multiple Sclerosis Treatment: Lauren B. … future remyelinating therapies.
Enhancing Multiple Sclerosis Diagnosis and Early Treatment …
-
Jefferies Maintains Buy Rating on Sanofi Despite Setback in Multiple Sclerosis
24 Dec 2025 12:57 GMT
… tolebrutinib in the treatment of multiple sclerosis.
In a research note, the … 3 trial in primary progressive multiple sclerosis (PPMS), in which tolebrutinib did … program, Sanofi's other multiple sclerosis project, remains completely unaffected by …
-
Mediterranean Diet Linked to Lower Multiple Sclerosis Risk
24 Dec 2025 11:01 GMT
… a significantly lower risk for multiple sclerosis (MS), with the impact especially … online on December 15 in Multiple Sclerosis Journal.
Expanding the Scope of …
-
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
24 Dec 2025 06:00 GMT
… in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. … treat non-relapsing secondary progressive multiple sclerosis (nrSPMS) in adult patients. … of non-relapsing secondary progressive multiple sclerosis and to slow disability …
-
Study Links Forever Chemicals to Increased Risk of Multiple Sclerosis
23 Dec 2025 19:07 GMT
… increase the likelihood of developing multiple sclerosis, according to new research that … the brain and the body
Multiple sclerosis is a chronic disease that … chemicals, reducing their exposure to sclerosis, by filtering drinking water, avoiding …